Browse drugs

…arning Objectives Discuss the different mechanisms of action of belimumab and anifrolumab and their roles in modulating immune pathways i…

…rienced an improvement 74.6% had managed to completely withdraw prednisone .77.6% were still on BEL treatment.Conclusions In the Spanish c…

…Objectives Belimumab (BEL) is a B-cell modulator targeting the central immunopathoge…

…llow-up, with a reduction in disease flares and sparing of both prednisone and cDMARDs. Moreover, this case series highlights that BEL mai…

…Objectives Belimumab (BEL) is an IgG1 antibody against the soluble form of B-cell ac…

…Objectives Belimumab (BEL), a B-cell modulator mAb that selectively inhibits soluble…

…Objective To assess the effectiveness of belimumab (BEL) in improving anaemia, thrombocytopenia, lymphopenia and l…

…Objectives Belimumab (BEL) is a B-cell modulating anti-BLyS mAb approved for SLE (20…

…Objectives Belimumab (BEL), a B-cell modulator mAb that selectively inhibits soluble…

…licated autoimmune disease characterized by recurrent relapses. Belimumab (BEL) is a humanized monoclonal antibody and has been approved …

…I was 0 (0-1.25). Standard treatments during pregnancy included prednisone (83%), antimalarials (86%), azathioprine (47%); calcineurin-inh…

…tive To evaluate the efficacy, safety and predictive factors of belimumab (BEL)-based triple therapy in proliferative lupus nephritis (LN…